FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma

Project Oncology® - Ein Podcast von ReachMD

Podimo 45 Tage kostenlos testen

Ein Universum voller exklusiver Podcasts und Hörbücher. Klicken Sie hier um loszulegen!

Werbung

FDA medical oncologists discuss the agency’s March 23, 2017 approval of avelumab for the treatment of patients 12 years and older with metastatic Merkel cell carcinoma. Released May 22, 2017

Visit the podcast's native language site